Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rodier

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Diabete & Metabolisme|June 1, 1987
Plasma lipid fatty acids and platelet function during continuous subcutaneous insulin infusion in type I diabetesL H Monnier, M Rodier, A Gancel, et al.
Lancet (London, England)|March 2, 1985
Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitusT Wilkin, P J Hoskins, M Armitage, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Induction of remissions of insulin-dependent diabetes by cyclosporin]G Feutren, L Papoz, R Assan, et al.
Diabetologia|October 16, 2007
Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot studyA Jeandrot, J-L Richard, C Combescure, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1990
A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapyB Vialettes, R Picq, M du Rostu, et al.
Diabetes & Metabolism|June 27, 2006
Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 yearD Raccah, H Hanaire-Broutin, C Sert-Langeron, et al.
Diabetes|July 1, 1990
Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulinR Assan, G Feutren, J Sirmai, et al.
Lancet (London, England)|July 19, 1986
Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trialG Feutren, L Papoz, R Assan, et al.
Diabetes Care|January 1, 1995
Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled studyJ L Richard, C Parer-Richard, J P Daures, et al.
Kidney International|April 12, 2000
Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study GroupC Lacquemant, C Gaucher, C Delorme, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Diabete & Metabolisme|June 1, 1987
Plasma lipid fatty acids and platelet function during continuous subcutaneous insulin infusion in type I diabetesL H Monnier, M Rodier, A Gancel, et al.
Lancet (London, England)|March 2, 1985
Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitusT Wilkin, P J Hoskins, M Armitage, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Induction of remissions of insulin-dependent diabetes by cyclosporin]G Feutren, L Papoz, R Assan, et al.
Diabetologia|October 16, 2007
Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot studyA Jeandrot, J-L Richard, C Combescure, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1990
A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapyB Vialettes, R Picq, M du Rostu, et al.
Diabetes & Metabolism|June 27, 2006
Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 yearD Raccah, H Hanaire-Broutin, C Sert-Langeron, et al.
Diabetes|July 1, 1990
Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulinR Assan, G Feutren, J Sirmai, et al.
Lancet (London, England)|July 19, 1986
Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trialG Feutren, L Papoz, R Assan, et al.
Diabetes Care|January 1, 1995
Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled studyJ L Richard, C Parer-Richard, J P Daures, et al.
Kidney International|April 12, 2000
Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study GroupC Lacquemant, C Gaucher, C Delorme, et al.
Pageof 10